Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
5.77
+0.06 (1.05%)
At close: May 12, 2025, 4:00 PM
5.49
-0.28 (-4.85%)
After-hours: May 12, 2025, 5:00 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $103.87 million as of May 12, 2025. Its market cap has increased by 336.71% in one year.
Market Cap
103.87M
Enterprise Value
116.24M
1-Year Change
336.71%
Ranking
Category
Stock Price
$5.77
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $103.87M, an increase of 64.60%. That is a compound annual growth rate of 9.24%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |